H. Irannejad et al. / Bioorg. Med. Chem. 18 (2010) 4224–4230
4229
350
300
250
200
150
100
50
added and the mixture was stirred for 2 h at room temperature.
The solvent was removed under reduced pressure. Water (20 ml)
and dichloromethane (50 ml) were added to the mixture. The or-
ganic phase was separated, dried (sodium sulfate), filtered and
evaporated under reduced pressure and the residue was crystal-
lized from methanol–water to yield 3-thioalkyl-5,6-diaryl-1,2,4-
triazines. The spectroscopic and analytical data of compounds are
as follows:
***
#
#
#
#
#
##
0
4.2.1.1. 3-Thiomethyl-5,6-diphenyl-1,2,4-triazine (5a-1). Mp: 89–
91 °C, 1H NMR (CDCl3) d: 2.70 (s, 3H, SCH3), 7.30–7.45 (m, 6H),
7.50–7.58 (m, 4H). Mass: m/z (%), 279 (M+, 7), 178 (25), 176
(100), 100 (5), 85 (15), Anal. Calcd for C16H13N3S: C, 68.79; H,
4.69; N, 15.04. Found: C, 68.57; H, 4.73; N, 14.96.
Figure 5. Inhibitory effect of compounds on accumulation of intracellular ROS.
DifferentiatedPC12cellswereincubated3 hwithtriazinederivatives(10 M)andthen
l
exposed to H2O2 for 24 h. Intracellular levels of reactive oxygen species were measured
with DCFH-DA. The median of three independent experiments is shown. *Significantly
different from control cells. #Significantly different from H2O2-treated cells.
4.2.1.2. 3-Thioethyl-5,6-diphenyl-1,2,4-triazine (5a-2). Mp: 70–
72 °C, 1H NMR (CDCl3) d: 1.52 (t, J = 7.5 Hz, 3H, SCH2–CH3), 3.37 (q,
J = 7.5 Hz, 2H, SCH2–CH3), 7.28–7.48 (m, 6H), 7.55–7.62 (m, 4H).
Mass: m/z (%), 293 (M+, 5), 178 (100), 176 (30), Anal. Calcd for
C17H15N3S: C, 69.59; H, 5.15; N, 14.32. Found: C, 69.48; H, 4.99;
N, 14.58.
tively, compared to H2O2-treated cells (Fig. 5). Preincubation of the
cells with 5b(1–4) (10 lM) reduced intracellular ROS by 2.26-,
1.46-, 1.53-, and 1.60-fold, respectively, compared to H2O2-treated
cells. It seems that in this signaling pathway ROS act as second
messengers. Because, ROS have been associated with neurodegen-
erative disease and recent studies have demonstrated that ROS,
over a narrow concentration range, might function as second mes-
sengers in cell-signaling pathways.3 Several data have shown that
4.2.1.3.
3-Thio-n-propyl-5,6-diphenyl-1,2,4-triazine
(5a-
3). Mp: 69–71 °C, 1H NMR (CDCl3) d: 1.10 (t, J = 7.4 Hz, 3H,
SCH2–CH2–CH3), 1.88–1.98 (m, 2H, SCH2–CH2–CH3), 3.31 (q,
J = 7.5 Hz, 2H, SCH2–CH2–CH3), 7.25–7.47 (m, 6H), 7.48–7.60 (m,
4H). Mass: m/z (%), 307 (M+, 8), 264 (12), 178 (20), 176 (100),
152 (5), 105 (37), 77 (19), Anal. Calcd for C18H17N3S: C, 70.33; H,
5.57; N, 13.67. Found: C, 70.51; H, 5.65; N, 13.75.
ROS activates NF-
protease, can be activated by ROS. So the suppressive effect of
our compounds on translocation of NF- B and also the expression
of active forms of caspase-3 shows that these triazine derivatives
suppress NF- B activating via suppression of ROS production.
j
B.28 In addition, caspase-3 a family of cysteine
j
j
4.2.1.4. 3-Thio-n-butyl-5,6-diphenyl-1,2,4-triazine (5a-4). Mp:
45–47 °C, 1H NMR (CDCl3) d: 0.81 (t, J = 7.3 Hz, 3H, SCH2–CH2–
CH2–CH3), 1.28–1.38 (m, 2H, SCH2–CH2–CH2–CH3), 1.78–1.96 (m,
2H, SCH2–CH2–CH2–CH3), 3.40 (q, J = 7.5 Hz, 2H, SCH2–CH2–CH2–
CH3), 7.34–7.48 (m, 6H), 7.51–7.59 (m, 4H). Mass: m/z (%), 321
(M+, 10), 264 (7), 178 (35), 176 (100), 149 (5), 85 (15), Anal. Calcd
for C19H19N3S: C, 70.99; H, 5.96; N, 13.07. Found: C, 71.09; H, 5.77;
N, 12.85.
3. Conclusion
In summary, our results clearly indicate that triazine derivatives
prevent the H2O2-induced cell death in differentiated PC12 cells. It
seems that in this cytoprotection, inhibitions of caspase-3 and NF-
jB via suppression of ROS production are the main factors which
protect neurons against oxidative stress-induced apoptosis. How-
ever, the complete molecular milieu that links all these events need
to be elucidated. A further study of the detailed mechanisms is now
in progress in our laboratory that will pave the way to exploiting pre-
ventive or therapeutic strategies for neurodegenerative diseases.
4.2.1.5. 3-Thiomethyl-5,6-(4-dicholrophenyl)-1,2,4-triazine (5b-
1). Mp: 137–139, °C 1H NMR (CDCl3) d: 2.70 (s, 3H, SCH3), 7.34 (d,
J = 9.0 Hz, 2H), 7.37 (d, J = 8.5 Hz, 2H), 7.45 (d, J = 9.0 Hz, 2H), 7.50
(d, J = 8.5 Hz, 2H). Mass: m/z (%), 347 (M+, 17), 245 (100), 176 (45),
123 (15), 63 (42), Anal. Calcd for C16H11Cl2N3S: C, 55.09; H, 3.18; N,
12.05. Found: C, 55.39; H, 3.24; N, 11.89.
4. Experimental
4.2.1.6. 3-Thioethyl-5,6-(4-dichlorophenyl)-1,2,4-triazine (5b-
2). Mp: 115–117 °C, 1H NMR (CDCl3) d: 1.48 (t, J = 7.4 Hz, 3H,
SCH2–CH3), 3.39 (q, J = 7.4 Hz, 2H, SCH2–CH3), 7.38 (d, J = 9.0 Hz,
2H), 7.40 (d, J = 8.5 Hz, 2H), 7.45 (d, J = 9.0 Hz, 2H), 7.50 (d,
J = 8.5 Hz, 2H). Mass: m/z (%), 361 (M+, 9), 247 (65), 245 (100),
209 (5), 175 (20), Anal. Calcd for C17H13Cl2N3S: C, 56.36; H, 3.62;
N, 11.60. Found: C, 56.45; H, 3.78; N, 11.75.
4.1. Instrumentation and chemicals
Melting points were determined with a Reichert-Jung hot-stage
microscope and are uncorrected. 1H NMR (500 MHz) spectra were
recorded on a Brucker spectrometer using CDCl3 or DMSO-d6 as
solvent. Chemical shifts (d) are reported in ppm relative to TMS
as internal standard. Infrared spectra were acquired on a Nicolet
Magna 550-FT spectrometer. Mass spectra were obtained with a
Finnigan Mat TSQ-70 spectrometer. Elemental microanalyses were
within 0.4% of the theoretical values for C, H, and N.
4.2.1.7. 3-Thio-n-propyl-5,6-(4-dichlorophenyl)-1,2,4-triazine
(5b-3). Mp: 88–90 °C, 1H NMR (CDCl3) d: 1.15 (t, J = 7.5 Hz, 3H,
SCH2–CH2–CH3), 1.88–1.95 (m, 2H, SCH2–CH2–CH3), 3.30 (q,
J = 7.5 Hz, 2H, SCH2–CH2–CH3), 7.30 (d, J = 9.1 Hz, 2H), 7.37 (d,
J = 8.3 Hz, 2H), 7.45 (d, J = 9.1 Hz, 2H), 7.48 (d, J = 8.3 Hz, 2H). Mass:
m/z (%), 375 (M+, 5), 333 (9), 248 (64) 246 (100), 176 (35), Anal.
Calcd for C18H15Cl2N3S: C, 57.45; H, 4.02; N, 11.17. Found: C,
57.29; H, 4.19; N, 10.87.
Antibodies directed against caspase-3, NF-jB, and b-actin were
obtained from Cell Signaling Company. All the other reagents, un-
less otherwise stated, were from Sigma–Aldrich (St. Louis, MO).
4.2. Synthesis
4.2.1. General procedures for preparation of triazine derivatives
(5)
To a stirring solution of compound 4 (1 mmol) in methanol
(50 ml), alkyl iodide (1.2 mmol), and triethylamine (1 ml) were
4.2.1.8. 3-Thio-n-butyl-5,6-(4-dicholorophenyl)-1,2,4-triazine
(5b-4). Mp: 90–91 °C, 1H NMR (CDCl3) d: 0.80 (t, J = 7.5 Hz, 3H,
SCH2–CH2–CH2–CH3), 1.31–1.40 (m, 2H, SCH2–CH2–CH2–CH3),